Canton Hathaway’s Boston Scientific BSX Stock Holding History

Canton Hathaway’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-265	Closed	-$25.3K	–	272
2025 Q4	$25.3K	Hold	265	–	–	﹤0.01%	253
2025 Q3	$26K	Hold	265	–	–	0.01%	253
2025 Q2	$28K	Hold	265	–	–	0.01%	242
2025 Q1	$27K	Hold	265	–	–	0.01%	246
2024 Q4	$24K	Hold	265	–	–	0.01%	224
2024 Q3	$22K	Hold	265	–	–	0.01%	239
2024 Q2	$20K	Buy	+265	New	+$19.4K	0.01%	238
2021 Q2	–	Sell	-110	Closed	-$4K	–	255
2021 Q1	$4K	Buy	+110	New	+$4.16K	﹤0.01%	300
2020 Q4	–	Sell	-100	Closed	-$4K	–	263
2020 Q3	$4K	Hold	100	–	–	﹤0.01%	272
2020 Q2	$4K	Buy	+100	New	+$3.6K	﹤0.01%	150
2020 Q1	–	Sell	-100	Closed	-$5K	–	144
2019 Q4	$5K	Hold	100	–	–	﹤0.01%	188
2019 Q3	$4K	Hold	100	–	–	﹤0.01%	194
2019 Q2	$4K	Buy	+100	New	+$3.85K	﹤0.01%	227

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Canton Hathaway's BSX Position: Q1 2026 in Review

Canton Hathaway sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 265 shares — an estimated $25.3K sold.

Canton Hathaway first reported a position in BSX in Q2 2019 and held it in 13 quarters. The position peaked at $28K in Q2 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Canton Hathaway reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Canton Hathaway sold 265 Boston Scientific shares in Q1 2026, an estimated $25.3K.
Canton Hathaway first reported a position in Boston Scientific in Q2 2019 and held it in 13 quarters.
Canton Hathaway's Boston Scientific position peaked at $28K in Q2 2025.
1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Canton Hathaway's 13F filing for Q1 2026, filed 24 Apr 2026.